Evidence map›Paper›PMID 23913414›Full record

ArticleNucleic acids research2013

XPD-dependent activation of apoptosis in response to triplex-induced DNA damage.

Meetu Kaushik Tiwari, Faye A Rogers

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. A distinct triplex DNA unwinding activity of ChlR1 helicase.The Journal of biological chemistry · 2015
    Article
  12. Article
  13. Article
  14. Article
  15. Triplex-induced DNA damage response.The Yale journal of biology and medicine · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Meetu Kaushik TiwariDepartment of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Faye A Rogers
Yale University · US

Funding

Altered Helical Structures: Repair and Induction of Genomic InstabilityK22CA120049 · NCI · YALE UNIVERSITY · PI ROGERS, FAYE A · 2006 to 2009
$553k
NCI NIH HHS K22 CA120049NCI NIH HHS K24 CA120049-03S1
6 · The paper itself

Abstract

DNA sequences capable of forming triplexes are prevalent in the human genome and have been found to be intrinsically mutagenic. Consequently, a balance between DNA repair and apoptosis is critical to counteract their effect on genomic integrity. Using triplex-forming oligonucleotides to synthetically create altered helical distortions, we have determined that pro-apoptotic pathways are activated by the formation of triplex structures. Moreover, the TFIIH factor, XPD, occupies a central role in triggering apoptosis in response to triplex-induced DNA strand breaks. Here, we show that triplexes are capable of inducing XPD-independent double strand breaks, which result in the formation of γH2AX foci. XPD was subsequently recruited to the triplex-induced double strand breaks and co-localized with γH2AX at the damage site. Furthermore, phosphorylation of H2AX tyrosine 142 was found to stimulate the signaling pathway of XPD-dependent apoptosis. We suggest that this mechanism may play an active role in minimizing genomic instability induced by naturally occurring noncanonical structures, perhaps protecting against cancer initiation.

Indexed as

ApoptosisDNADNA DamageAnimalsCell LineDNA Breaks, Double-StrandedDNA RepairGenomic InstabilityMiceXeroderma Pigmentosum Group D ProteinDNAtriplex DNAXeroderma Pigmentosum Group D Protein

Identifiers

PMID23913414
PMCPMC3799437
OpenAlexW2100784086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.